Digital
Digital twins in healthcare and drug discovery: From idea to success stories
The term "digital twins" has its origins in engineering and computer …
19715 items found
News
Daiichi Sankyo’s Ezharmia cleared in Japan for rare lymphoma
Daiichi Sankyo has a second approval in Japan for Ezharmia, its …
News
Cholesterol drug could find new role in diabetic eye disease
A decades-old drug used to lower cholesterol levels in the blood has …
News
BMS gets FDA approval for Krazati in colorectal cancer
Bristol-Myers Squibb’s KRAS inhibitor Krazati has been approved for a …
News
Vertex islet cell therapy gets type 1 diabetics off insulin
Three people with type 1 diabetes who received Vertex Pharma’s islet …
News
FDA clears Argenx’ Vyvgart Hytrulo for rare disease CIDP
Netherlands biotech Argenx has a second FDA approval for its FcRn …
Oncology
Patients
Sustainable innovation for patients, people, and planet
Sustainability is all important for the planet and its people, and in …
R&D
The new genomic frontier: Next-generation data management takes flight
Genomics is changing the world. It will revolutionise healthcare for …
News
Chimps’ self-medication with plants could aid drug discovery
A landmark study has revealed that wild chimpanzees use medicinal …
News
NWEH says module cuts side effect reporting burden in trials
Monitoring patient safety is of the utmost importance when running a …
News
Gilead’s twice-yearly HIV PrEP 100% effective, says study
Gilead Sciences’ already dominant position in HIV pre-exposure …
Patients
The power of patient insights in shaping successful drug dev...
The pharmaceutical industry is undergoing a major transformation, placing patients at the forefront of drug development like never before.
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
R&D
LSX 2024 - Dr Tadaaki Taniguchi
At LSX in Boston last month, editor-in-chief Jonah Comstock caught up with Dr Tadaaki Taniguchi, chief medical officer at Astellas Pharmaceuticals to talk a bit about the company and some r
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
BIO-Europe's 30th Anniversary Landmark Event in Stockholm
BIO-Europe™ celebrates 30 years of facilitating partnerships this Fall. In 1994, BIO-Europe launched with the mission to drive biotech innovation and
R&D
Partner Content
8th Dermatology Drug Development Summit
Industry’s Destination to Discover & Develop Best-In-Class Drugs for Immuno-Inflammatory Skin Disease
